PH12014502171A1 - Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid - Google Patents

Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid

Info

Publication number
PH12014502171A1
PH12014502171A1 PH12014502171A PH12014502171A PH12014502171A1 PH 12014502171 A1 PH12014502171 A1 PH 12014502171A1 PH 12014502171 A PH12014502171 A PH 12014502171A PH 12014502171 A PH12014502171 A PH 12014502171A PH 12014502171 A1 PH12014502171 A1 PH 12014502171A1
Authority
PH
Philippines
Prior art keywords
bromobenzoyl
amino
phenylacetic acid
aqueous composition
composition containing
Prior art date
Application number
PH12014502171A
Other languages
English (en)
Inventor
Morimoto Takashi
Asada Hiroyuki
Takahashi Kyohei
Okamoto Tomoyuki
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of PH12014502171A1 publication Critical patent/PH12014502171A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PH12014502171A 2012-03-28 2014-09-26 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid PH12014502171A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012073181 2012-03-28
PCT/JP2013/059211 WO2013147000A1 (ja) 2012-03-28 2013-03-28 2-アミノ-3-(4-ブロモベンゾイル)フェニル酢酸含有水性組成物

Publications (1)

Publication Number Publication Date
PH12014502171A1 true PH12014502171A1 (en) 2014-12-10

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014502171A PH12014502171A1 (en) 2012-03-28 2014-09-26 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid

Country Status (9)

Country Link
JP (1) JP5922609B2 (enExample)
KR (1) KR20140139501A (enExample)
CN (1) CN104203224A (enExample)
IN (1) IN2014DN07767A (enExample)
MY (1) MY170840A (enExample)
PH (1) PH12014502171A1 (enExample)
SG (1) SG11201405837YA (enExample)
TW (1) TWI604858B (enExample)
WO (1) WO2013147000A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017002042A (ja) * 2015-06-10 2017-01-05 参天製薬株式会社 点眼剤、及び点眼剤防腐効力維持方法
KR20200099547A (ko) * 2017-12-14 2020-08-24 산텐 세이야꾸 가부시키가이샤 2-아미노-3-(4-브로모벤조일)페닐아세트산 또는 그의 염을 함유하는 점안제
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (ja) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd 眼科用医薬組成物
ES2381672T3 (es) * 2003-11-14 2012-05-30 Senju Pharmaceutical Co., Ltd. Preparación en solución acuosa que comprende un antibiótico aminoglicósido y bromfenaco
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
CA2716110A1 (en) * 2008-02-21 2009-08-27 Tim Mcnamara Ophthalmic nsaids as adjuvants
CN101322683B (zh) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法
KR102075173B1 (ko) * 2011-01-18 2020-02-07 센주 세이야꾸 가부시키가이샤 보존 효력을 갖는 브롬페낙 수성 액제 조성물
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物

Also Published As

Publication number Publication date
JP5922609B2 (ja) 2016-05-24
JP2013227300A (ja) 2013-11-07
MY170840A (en) 2019-09-10
TW201343197A (zh) 2013-11-01
SG11201405837YA (en) 2014-11-27
CN104203224A (zh) 2014-12-10
KR20140139501A (ko) 2014-12-05
IN2014DN07767A (enExample) 2015-05-15
TWI604858B (zh) 2017-11-11
WO2013147000A1 (ja) 2013-10-03

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
JO3317B1 (ar) مركبات تترا هيدروبيرولو ثيازين
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201390081A1 (ru) Дейтерированный n-этил-n-фенил-1,2-дигидро-4-гидрокси-5-хлор-1-метил-2-оксохинолин-3-карбоксамид, его соли и их применение
IN2015DN00402A (enExample)
GB201211120D0 (en) Antagonist to an enzyme and/or a metabolite of the kynurenine pathway
EA201690894A1 (ru) Феноксиэтилы
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
IL241245A (en) Bicyclo [2.2.1] acid gpr120 modulators
UA115072C2 (uk) Похідні гідантоїну
PH12014502171A1 (en) Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid
IN2015DN02668A (enExample)
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
MX341189B (es) Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.
CL2015002350A1 (es) Composición agroquimica en suspensión acuosa
ZA201505170B (en) Tablets with improved acceptance and good storage stability
MX2015012211A (es) Liquidos ionicos y usos de los mismos.
PL2919755T3 (pl) Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional
MY182059A (en) Pharmaceutical composition for external use
ZA201503574B (en) Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine
BR112015021178A2 (pt) derivados de 3-{heterociclil[(heterociclilmetóxi)imino]metil}-oxadiazolona fungicida
IN2015DN03114A (enExample)
WO2015059044A3 (en) Cell differentiation marker and its uses
IN2014KN00835A (en) Biocide